Cathy McMorris Rodgers - Chair of the House Energy and Commerce Committee | Official U.S. House headshot
Cathy McMorris Rodgers - Chair of the House Energy and Commerce Committee | Official U.S. House headshot
Congressman Brett Guthrie and Congressman Earl L. "Buddy" Carter have announced a hearing focused on the impact of Pharmacy Benefit Managers (PBMs) on competition and drug costs. The hearing, titled "An Examination of How Reining in PBMs Will Drive Competition and Lower Costs for Patients," will be held by the Subcommittee on Health.
The Chairmen highlighted concerns about consolidation in the PBM market, which they say has resulted in fewer choices for patients and employers. This lack of competition is believed to contribute to higher out-of-pocket drug expenses. "As outlined in recent reports, significant consolidation in the PBM marketplace has led to fewer options for patients and employers and less competition to keep out-of-pocket drug costs in check," said Chairmen Guthrie and Carter.
The hearing is scheduled for Wednesday, February 26, 2025, at 10:00 AM ET at the Rayburn House Office Building. It will be open to both the public and press, with a live stream available online at energycommerce.house.gov.
For further information regarding the hearing or press inquiries, contact Emma Schultheis or Christopher Krepich via their respective emails provided by the committee staff.
Alerts Sign-up